SCHEMBL9257022

SCHEMBL9257022

CCOC(=O)CCNC(=O)c1ccc2c(c1)nc(-c1ccc(C(=N)NC(=O)OC)cc1)n2C

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.48
HDAC8 Q9BY41 3/20 0.48
HDAC6 Q9UBN7 3/20 0.48
HDAC3 O15379 2/20 0.48
HDAC2 Q92769 2/20 0.48
PTGER4 P35408 6/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
NAMPT P43490 3/20 0.41
RIPK2 O43353 1/20 0.40
SIRT2 Q8IXJ6 2/20 0.39
SIRT1 Q96EB6 2/20 0.39
BCHE P06276 1/20 0.38
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9254153 0.94 HDAC1 (0.51) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9251884 0.88 HDAC1 (0.50) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9245464 0.88 HDAC6 (0.48) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9248580 0.85 HDAC1 (0.51) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL8863519 0.82 HDAC1 (0.52) HDAC1HDAC8HDAC6HDAC3HDAC2
Hydrochloric Acid SCHEMBL9255053 0.81 HDAC1 (0.51) HDAC1HDAC8HDAC6HDAC3HDAC2
Hydrochloric Acid SCHEMBL9249232 0.80 HDAC1 (0.46) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9251361 0.79 HDAC6 (0.55) HDAC1HDAC8HDAC6HDAC3HDAC2
Hydrochloric Acid SCHEMBL9252320 0.78 HDAC1 (0.51) HDAC1HDAC8HDAC6HDAC3HDAC2
SCHEMBL9255968 0.78 HDAC1 (0.51) HDAC1HDAC8HDAC6HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5434150-A Anticoagulants, cardiovascular disorders DR. KARL THOMAE GMBH (DE) 1995-07-18 US disclosed
EP-0531883-A1 Condensed 5-membered ring heterocycles, process for their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1993-03-17 EP disclosed